January 24, 2018 5:07 AM ET


Company Overview of Kanyos Bio, Inc.

Company Overview

Kanyos Bio, Inc. develops antigen-specific immune tolerance technology for autoimmune indications, including type-1 diabetes and celiac disease. The company focuses on translating the antigen-specific immune tolerance technology to develop targeted treatments for type-1 diabetes and celiac disease. Kanyos Bio, Inc. was formerly known as Lumberjill Therapeutics, Inc. The company was incorporated in 2014 and is based in Cambridge, Massachusetts.

Cambridge, MA 

United States

Founded in 2014

Key Executives for Kanyos Bio, Inc.

Founder and Chairman
Age: 59
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kanyos Bio, Inc., please visit www.kanyosbio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.